Jenny Byrne

5.8k total citations
124 papers, 3.1k citations indexed

About

Jenny Byrne is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Jenny Byrne has authored 124 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Hematology, 34 papers in Genetics and 32 papers in Oncology. Recurrent topics in Jenny Byrne's work include Hematopoietic Stem Cell Transplantation (45 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (28 papers). Jenny Byrne is often cited by papers focused on Hematopoietic Stem Cell Transplantation (45 papers), Acute Myeloid Leukemia Research (29 papers) and Acute Lymphoblastic Leukemia research (28 papers). Jenny Byrne collaborates with scholars based in United Kingdom, United States and France. Jenny Byrne's co-authors include Nigel H. Russell, Gareth J. Morgan, Gordon Cook, Roger G. Owen, Sue Bell, J. Anthony Child, Walter M. Gregory, Faith E. Davies, Sylvia Feyler and Mark T. Drayson and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Jenny Byrne

114 papers receiving 3.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Jenny Byrne	2.2k	1.0k	853	586	416	124	3.1k
Andrzej Hellmann	2.0k 0.9×	1.1k 1.1×	834 1.0×	1.1k 1.9×	940 2.3×	130	4.0k
T. de Witte	3.1k 1.4×	843 0.8×	918 1.1×	708 1.2×	788 1.9×	112	4.2k
Anthony P. Schwarer	2.1k 1.0×	591 0.6×	1.1k 1.3×	378 0.6×	886 2.1×	119	3.3k
Hee‐Je Kim	2.0k 0.9×	736 0.7×	464 0.5×	605 1.0×	717 1.7×	271	3.0k
Andreas Hirt	1.3k 0.6×	598 0.6×	430 0.5×	312 0.5×	856 2.1×	89	3.1k
Gerald J. Elfenbein	1.5k 0.7×	1.0k 1.0×	356 0.4×	482 0.8×	696 1.7×	97	3.2k
Yves Chalandon	2.3k 1.0×	995 1.0×	553 0.6×	494 0.8×	761 1.8×	192	4.3k
Denis Guyotat	1.9k 0.9×	1.0k 1.0×	459 0.5×	956 1.6×	553 1.3×	124	3.4k
Giuseppe Milone	2.2k 1.0×	851 0.8×	366 0.4×	1.2k 2.0×	466 1.1×	142	3.2k
Amin M. Alousi	2.5k 1.2×	902 0.9×	569 0.7×	641 1.1×	940 2.3×	244	3.7k

Countries citing papers authored by Jenny Byrne

Since Specialization

Citations

This map shows the geographic impact of Jenny Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Byrne more than expected).

Fields of papers citing papers by Jenny Byrne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Byrne. The network helps show where Jenny Byrne may publish in the future.

Co-authorship network of co-authors of Jenny Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Byrne. A scholar is included among the top collaborators of Jenny Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Byrne. Jenny Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sedehizadeh, Saam, et al.. (2025). Expanding the clinical spectrum of NHP2-related dyskeratosis congenita: a case with novel phenotypic features. Clinical Dysmorphology. 34(3). 83–87.

Robertson, H, Dragana Milojković, Nauman M. Butt, et al.. (2024). Expectations and outcomes of varying treatment strategies for CML presenting during pregnancy. British Journal of Haematology. 205(3). 947–955. 6 indexed citations

Baron, Frédéric, Myriam Labopin, Jurjen Versluis, et al.. (2024). Higher survival following transplantation with a mismatched unrelated donor with posttransplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis than with double unit umbilical cord blood in patients with acute myeloid leukemia in first complete remission: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. American Journal of Hematology. 99(12). 2296–2305.

Nagler, Arnon, Myriam Labopin, Stephan Mielke, et al.. (2023). Matched related versus unrelated versus haploidentical donors for allogeneic transplantation in AML patients achieving first complete remission after two induction courses: a study from the ALWP/EBMT. Bone Marrow Transplantation. 58(7). 791–800. 7 indexed citations

Beksaç, Meral, Nicolaus Kröger, Jenny Byrne, et al.. (2020). Allogeneic hematopoietic cell transplantation (allo-HCT) outcomes in myeloma patients on renal replacement therapy: a report from the Chronic Malignancy Working Party (CMWP) of the European Society of Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 56(3). 529–531. 1 indexed citations

Gilleece, Maria, Myriam Labopin, Bipin N. Savani, et al.. (2019). Allogeneic haemopoietic transplantation for acute myeloid leukaemia in second complete remission: a registry report by the Acute Leukaemia Working Party of the EBMT. Leukemia. 34(1). 87–99. 24 indexed citations

Claudiani, Simone, Silvia Metelli, Richard Szydlo, et al.. (2019). Introducing a Predictive Score for Successful Treatment Free Remission in Chronic Myeloid Leukemia (CML). Blood. 134(Supplement_1). 26–26. 8 indexed citations

O’Brien, Stephen J., Letizia Foroni, Wendy Osborne, et al.. (2018). Spirit 2: Final 5 Year Analysis of the UK National Cancer Research Institute Randomized Study Comparing Imatinib with Dasatinib in Patients with Newly Diagnosed Chronic Phase CML. Blood. 132(Supplement 1). 457–457. 10 indexed citations

Jackson, Carlos T., et al.. (2018). Antipsychotic adherence and emergency department utilization among patients with schizophrenia. Schizophrenia Research. 201. 347–351. 8 indexed citations

10.

Clark, Richard E., Jane F. Apperley, Christopher Pocock, et al.. (2016). Chronic Myeloid Leukaemia Patients with Stable Molecular Responses (at least MR3) May Safely Decrease the Dose of Their Tyrosine Kinase Inhibitor: Data from the British Destiny Study. Blood. 128(22). 938–938. 6 indexed citations

11.

O’Brien, Stephen G., Sarah Adams, Letizia Foroni, et al.. (2014). Spirit 2: An NCRI Randomised Study Comparing Dasatinib with Imatinib in Patients with Newly Diagnosed CML. Blood. 124(21). 517–517. 24 indexed citations

12.

Shaw, Bronwen E., Jenny Byrne, Claire Seedhouse, et al.. (2014). Caspase-8 polymorphisms result in reduced Alemtuzumab-induced T-cell apoptosis and worse survival after transplantation. Bone Marrow Transplantation. 50(2). 237–243. 1 indexed citations

13.

Bishton, Mark, et al.. (2007). High dose melphalan or intermediate dose melphalan can be well tolerated and result in good response rates in selected elderly patients with myeloma. Leukemia Research. 31(8). 1063–1068. 2 indexed citations

14.

Russell, Nigel H., et al.. (2005). Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplantation. 36(5). 437–441. 75 indexed citations

15.

Feng, Liang, Mark W. Drummond, Jenny Byrne, et al.. (2002). Molecular monitoring of complete cytogenetic responders following treatment with imatinib (STI571, Gleevec) for CML: A report from the UKSTI571 study group.. Blood. 100(11). 1425. 7 indexed citations

16.

Byrne, Jenny, et al.. (2001). Successful engraftment of a second transplant using non-myeloablative conditioning as treatment for graft failure following unrelated donor BMT. Bone Marrow Transplantation. 27(5). 547–549. 4 indexed citations

17.

Russell, NH, Gavin Cull, Jenny Byrne, et al.. (1999). Evaluation of non-myeloablative conditioning combining beam with in vivo pre-transplant Campath-IG for allogeneic transplantation in patients with lymphoma.. Blood. 94. 5 indexed citations

18.

Byrne, Jenny, et al.. (1998). THE MOLECULAR PATHOPHYSIOLOGY OF MYELOID LEUKAEMIAS: Ras REVISITED. British Journal of Haematology. 100(2). 256–264. 35 indexed citations

19.

Byrne, Jenny, et al.. (1998). Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxis. Bone Marrow Transplantation. 22(6). 541–545. 19 indexed citations

20.

Byrne, Jenny, et al.. (1969). Laboratory studies on the rimino-phenazines.. PubMed. 50. Suppl:22–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact